![David Wambeke](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Wambeke
Geen lopende functies
Vermogen: 8 M $ op 31-07-2026
Profiel
David John Wambeke worked at Craig-Hallum Capital Group LLC from 2007 to 2023, including the role of Partner & Managing Director in 2023.
From 2023 to 2025, worked at DiaMedica Therapeutics, Inc. as Chief Business Officer.
Attended the University of Minnesota for undergraduate studies.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-06-2025 | 527.114 ( 0,98% ) | 3 M $ | 31-07-2026 | |
| 01-06-2024 | 527.114 ( -.--% ) | 3 M $ | 31-07-2026 | |
INEO Tech Corp.
 INEO Tech Corp. Advertising/Marketing ServicesCommercial Services Operates location-based advertising, analytics and theft detection platform for retailers 19,93% | 18-06-2026 | 10.374.430 ( 19,93% ) | 757 333 $ | 31-07-2026 |
NeuroOne Medical Technologies Corp.
 NeuroOne Medical Technologies Corp. Medical SpecialtiesHealth Technology Develops thin film electrode technology for epileptic patients 1,92% | 01-03-2026 | 166.667 ( 1,92% ) | 281 667 $ | 31-07-2026 |
Eerdere bekende functies van David Wambeke
| Bedrijven | Functie | Einde |
|---|---|---|
| DIAMEDICA THERAPEUTICS INC. | Corporate Officer/Principal | 01-10-2025 |
Craig-Hallum Capital Group LLC
 Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01-03-2023 |
Opleiding van David Wambeke
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
93
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Craig-Hallum Capital Group LLC
Craig-Hallum Capital Group LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
